NSN 6505-01-204-5298 of Naproxen Tablets Us - Parts Details
| Alternative NSN: 6505012045298 |
| Item Name: Naproxen Tablets Us |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 012045298 |
| NCB Code: USA (01) |
| Manufacturers: Mylan Institutional Llc , Syntex Laboratories Inc , Major Pharmaceuticals Llc , Teva Pharmaceuticals Usa Inc , Geneva Pharmaceuticals Inc , Roche Laboratories Inc |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC51079-0794-20, NDC18393-0273-53, NDC00904-5590-60, NDC00903-0148-01, NDC00781-1164-13 under NSN 6505-01-204-5298 of Naproxen Tablets Us manufactured by Mylan Institutional Llc, Syntex Laboratories Inc, Major Pharmaceuticals Llc, Teva Pharmaceuticals Usa Inc, Geneva Pharmaceuticals Inc.
Federal Supply Class of NSN 6505-01-204-5298 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-204-5298, 6505012045298
-
Part No Manufacturer Item Name QTY RFQ NDC51079-0794-20 Mylan Institutional Llc naproxen tablets us Avl RFQ NDC18393-0273-53 Syntex Laboratories Inc naproxen tablets us Avl RFQ NDC00904-5590-60 Major Pharmaceuticals Llc naproxen tablets us Avl RFQ NDC00903-0148-01 Teva Pharmaceuticals Usa Inc naproxen tablets us Avl RFQ NDC00781-1164-13 Geneva Pharmaceuticals Inc naproxen tablets us Avl RFQ NDC00004-6314-01 Roche Laboratories Inc naproxen tablets us Avl RFQ 00904559060 Major Pharmaceuticals Llc naproxen tablets us Avl RFQ 00903014801 Teva Pharmaceuticals Usa Inc naproxen tablets us Avl RFQ 00004631401 Roche Laboratories Inc naproxen tablets us Avl RFQ
Characteristics Data of NSN 6505012045298MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT CBBL FEATURES PROVIDED UNIT DOSE CQCT PRIMARY CONTAINER TYPE STRIP CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY NAPROXEN TABLETS USP 375MG 100S PG MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT |
| CBBL | FEATURES PROVIDED | UNIT DOSE |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN TABLETS USP 375MG 100S PG |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |